These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7357504)

  • 1. Past and future role of the Organ Site Programs.
    Rhoads JE
    Cancer; 1980 Mar; 45(5 Suppl):1090-2. PubMed ID: 7357504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Past and current problems in tumor research].
    von Wasielewski E; Sedlacek HH
    Dtsch Med Wochenschr; 1986 Apr; 111(16):630-7. PubMed ID: 3956405
    [No Abstract]   [Full Text] [Related]  

  • 3. NCI's cancer therapy evaluation program: a commitment to treatment trials.
    Abrams JS; Murgo A; Christian MC
    Cancer Treat Res; 2007; 132():31-50. PubMed ID: 17305016
    [No Abstract]   [Full Text] [Related]  

  • 4. The Organ Site Programs and the National Cancer Program.
    King TJ
    Cancer Res; 1977 Aug; 37(8 Pt 2):2743-4. PubMed ID: 872100
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials 'must compete for new funds'.
    Gavaghan H
    Nature; 1994 Jun; 369(6482):597. PubMed ID: 8208276
    [No Abstract]   [Full Text] [Related]  

  • 6. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer research program strategy and planning--the use of contracts for program implementation.
    Baker CG
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910
    [No Abstract]   [Full Text] [Related]  

  • 8. As memory serves--an informal history of the National Cancer Institute, 1937-57.
    Shimkin MB
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):559-600. PubMed ID: 328903
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer control: implications from its history.
    Breslow L; Agran L; Breslow DM; Morganstern M; Ellwein L
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):671-86. PubMed ID: 328911
    [No Abstract]   [Full Text] [Related]  

  • 10. Translational research--traffic on the bridge.
    Bast RC; Mills GB; Young RC
    Biomed Pharmacother; 2001 Nov; 55(9-10):565-71. PubMed ID: 11769968
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 13. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis.
    Cherian MG; Huang PC; Klaassen CD; Liu YP; Longfellow DG; Waalkes MP
    Cancer Res; 1993 Feb; 53(4):922-5. PubMed ID: 8428370
    [No Abstract]   [Full Text] [Related]  

  • 14. Five years into the National Cancer Program: retrospective perspectives--the National Cancer Act of 1971.
    Schmidt BC
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):687-92. PubMed ID: 328912
    [No Abstract]   [Full Text] [Related]  

  • 15. National Institutes of Health Consensus Development Conference Statement: CEA (carcinoembryonic antigen): its role as a marker in the management of cancer.
    N C Med J; 1981 Sep; 42(9):660-4. PubMed ID: 6946297
    [No Abstract]   [Full Text] [Related]  

  • 16. The linear array.
    Zubrod CG; Schepartz SA; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488
    [No Abstract]   [Full Text] [Related]  

  • 17. From the editor. Translational Research Working Group roadmaps for cancer research.
    Bates SE
    Clin Cancer Res; 2008 Sep; 14(18):5663. PubMed ID: 18794073
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of research in cancer diagnosis.
    Berlin NI
    Mayo Clin Proc; 1975 May; 50(5):249-54. PubMed ID: 1092925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientists recall progress and promise of translational research.
    Marwick C
    J Natl Cancer Inst; 2001 Jan; 93(1):13-5. PubMed ID: 11136835
    [No Abstract]   [Full Text] [Related]  

  • 20. AACR-NCI-EORTC-15th symposium molecular targets and cancer therapeutics: enzyme inhibitors and anti-angiogenics.
    Mayfield R
    IDrugs; 2004 Jan; 7(1):19-21. PubMed ID: 14968809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.